marrow transplantation are limited by shortage of compatible donors and by significant costs and risks, efforts have been focused on the development of alternative clinical treatment, including gene therapy. So far, conventional gene therapy approaches, based on virus-mediated delivery of functional copies of the gene, have been relatively unsuccessful. 1 In contrast, gene targeting methodologies that repair the mutant gene in situ seem particularly attractive since theoretically they allow appropriate expression of the target gene, which remains in its native chromosomal environment.
2 In this study, we used a gene targeting approach that employed small DNA fragments (SDF) to directly modify several disease-causing loci. [3] [4] [5] [6] [7] We evaluated this approach in terms of its effectiveness in introducing or eliminating the most common Italian HBB mutation (β 39 C→T) in primary erythroid progenitor cells of normal or β-thalassemic individuals, respectively. Differentiation into erythroid progenitor cells was allowed to light-density mononuclear cells (MNC) and enriched hematopoietic CD34 + cells, separated from umbilical cord blood or peripheral blood of normal donors, and from peripheral blood or bone-marrow of β-thalassemic patients, as described elsewhere.
8 Two different SDF of 517-bp and 190-bp were generated by polymerase chain reaction (PCR) using intronic primers and genomic DNA from normal subjects (wild type fragment) or from homozygous β 39/ β 39 patients (mutant fragment). To evaluate the optimal method of intracellular delivery of exogenous DNA into the erythroid progenitor cells, the pEGFP reporter plasmid (Clontech) was used to compare chemical (Lipofectamine, SuperFect) and physical (electroporation) systems assessed by flow cytometric analysis. While both Lipofectamine and Superfect were relatively ineffective at delivering the reporter plasmid to this subset of hematopoietic cells, electroporation (using BTX ECM 830 apparatus) was more efficient with a transfection efficiency of about 10-12%. However, the transfection efficiency decreased to levels below 0.6% when fluoroscein isothiocyanate (FITC)-labeled SDF were electroporated into the target cells. Initially, seminested PCR were carried out on gel-purified genomic DNA and cDNA isolated from erythroid progenitor cells from normal donors, using primers external to the fragments (HB3/HB4 for DNA and HB5/HB6 for cDNA), and then allele-specific primers (B39N or B39M). Mutant SDF were able to introduce the β 39 mutation both at DNA and mRNA levels. Direct sequence analysis of PCR products also showed a heterozygous C to T transition in all samples (data not shown). Because the mutation creates a novel BfaI restriction site, site-specific modification could also be assayed by restriction fragment length polymorphism (RFLP) analysis of DNA, showing the appearance of the heterozygous additional bands (275-and 150-bp) after digestion of 527-bp PCR products (Figure 1) . To obtain an approximate quantification of the frequency of targeted cells in this model system, we cloned semi-nested PCR products into pGEM vector (Promega) and then screened 123 individual bacterial colonies by allele-specific PCR. The detection of three mutant colonies carrying the β 39 sequence suggested that the efficiency of short-fragment homologous replacement (SFHR)-mediated modification was approximately 2.4%. Secondly, erythroid precursor cells, expanded from peripheral blood and bone marrow of homozygous patients, were electroporated with wild-type fragments. Targeted correction was detected in eight of ten different experiments, as determined by allele-specific amplification performed on both genomic DNA and mRNA (Figure 2 ). Direct sequence analysis carried out on positive PCR samples showed the presence of both wild-type and β39 sequences.
Different gene targeting strategies have already shown that site-specific correction of a single point mutation in the HBB gene can be achieved, but with variable efficiencies. 7, 9 In this study, successful correction was routinely observed when 10 6 cells were electroporated with 1 or 2 µg of 517bp SDF. When the number of cells or the amount of fragment was reduced, no sequence-specific modification was detected, indicating that the ratio of SDF/cellular target is a fundamental factor for successful gene repair. 7 Molecular analysis showed that both the 517-and 190-bp long SDF were able to mediate se - 
